Differences in behaviour of three biopolymer constituents in coagulation with polyaluminium chloride: Implications for the optimisation of a coagulation-membrane filtration process.

Coagulation is often applied as a pre-treatment for membrane processes to reduce dissolved organic matter and to prevent membrane fouling. Biopolymers (BPs) have repeatedly been reported as major organic foulants, and coagulation conditions such as pH or dose have been optimised to minimise the remaining BPs. Optimisation however remains problematic because of the complex and heterogenetic nature of BP.